Biotechnology
Inhibrx news and milestones
Inhibrx: 5 headlines on record, 5 headlines in the last 90 days. Its story counts 8 milestones.
Data updated Nov 22, 2026 · Back to the company report
5Headlines
5In 90 days
8Milestones
Headlines
Sep 292026
News · YahooFinance
Inhibrx Biosciences (INBX) has drawn investor attention after a sharp move in the share price. The US$101.71 close now sits alongside a year-to-date gain of about 35%. Recent tra…
Sep 252026
News · Inhibrx Biosciences stock reports stronger cancer study data
Inhibrx Biosciences stock was priced at USD 100.40 on September 24, 2026, after Phase 2 data for INBRX-106. The study showed a 48.3 percent response rate.
Sources: the outlets named on each headline, each story once
Milestones
Aug 31, 2023
May 20, 2019
Apr 30, 2018
Aug 15, 2017
Feb 10, 2017
2017
Founded
Each milestone is dated by its source: registers, filings, the press
How to cite
Inhibrx, News. Alion, Nov 22, 2026. https://alion.io/company/inhibrx/news
